Dear Reader,

On Tuesday, February 3, we’re doing something a little unusual…

With so many alarm bells ringing in the market – from warnings over an AI bubble to the dramatic bull market in gold…

We’re selecting the very best ideas from across the entire Stansberry Research business… and putting them all together in a single, “all-in-one” portfolio.

We’ll be releasing this portfolio right after the markets close.

And we think it’s the ONE place every single one of our readers needs to seriously consider putting money in 2026.

Here’s how you can access it.

Building a portfolio like this would usually be out of the question for most of our readers.

First, you’d need to have the time to read all of our research across 20-plus different publications. (This would cost $34,000.)

Then, you’d need to review hundreds of different recommendations and select the ones that fit together the best.

And of course, you’d need to constantly manage and update it as the markets move.

But as part of this very special project, you don’t need to do any of that.

There’s no huge time or financial commitment…

And it’s very straightforward to follow along from home.

Just click here before February 3 for the full details.

Regards,

Matt Weinschenk
Publisher & Director of Research, Stansberry Research

Published by Stansberry Research.

You have received this e-mail as part of your subscription to Stansberry Digest. If you no longer wish to receive special offers from Stansberry Digest, click here.

You’re receiving this e-mail at pahovis@aol.com. Stansberry Research welcomes comments or suggestions at feedback@stansberryresearch.com. This address is for feedback only. For questions about your account or to speak with customer service, call 888-261-2693 (U.S.) or 443-839-0986 (international) Monday-Friday, 9 a.m.-5 p.m. Eastern time. Or e-mail info@stansberryresearch.com. Please note: The law prohibits us from giving personalized financial advice.

© 2026 Stansberry Research. All rights reserved. Any reproduction, copying, or redistribution, in whole or in part, is prohibited without written permission from Stansberry Research, 1125 N Charles St, Baltimore, MD 21201stansberryresearch.com.